Status:
COMPLETED
Screening for Genetic Forms of Diabetes in Convention of Care for Children and Adolescents With Diabetes (GENEPEDIAB)
Lead Sponsor:
Université Catholique de Louvain
Conditions:
Diabetes Mellitus
MODY
Eligibility:
All Genders
Up to 50 years
Phase:
NA
Brief Summary
Background/Aims: Diabetes, which affects 420 million people worldwide with a continuously rising incidence, is defined by a state of chronic hyperglycemia; a criterion referring to a heterogeneous gro...
Detailed Description
BACKGROUND: Diabetes currently affects 420 million people worldwide, a number that is expected to increase to 642 million in 2040. This disease is responsible for a high morbidity rate and an overall...
Eligibility Criteria
Inclusion
- Age between 0 and 18 years at the age of diabetes diagnosis.
- Patients followed and/or diagnosed within diabetes care agreements of the pediatric endocrinology departments participating in the study.
Exclusion
- none
Key Trial Info
Start Date :
October 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2022
Estimated Enrollment :
446 Patients enrolled
Trial Details
Trial ID
NCT04021199
Start Date
October 22 2018
End Date
June 22 2022
Last Update
July 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques universitaires Saint-Luc - UCLouvain
Brussels, Belgium, 1200